CLU and early-onset autosomal dominant Alzheimer disease: Increased plasma levels of clusterin in humans have been associated with prevalent Alzheimer’s disease and with the severity of disease, but not with incident Alzheimer’s disease [34], suggesting that increased clusterin levels and/or expression may be caused by the disease, and not vice versa (in epidemiology, this phenomenon is called reverse causation).